glp-1 generic drugs Mounjaro, Zepbound: May Soon Be Available Shortages improve for Lilly's GLP-1
Description
These findings highlight the importance of targeted therapeutic strategies based on HF phenotypes
The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease
| 228 comments on LinkedIn
Disclaimer: This article is for informational purposes only and is not medical advice
